Pharmaceutical Giredi 1009119-65-6 Daclatasvir Yochizira Hepatitis C

Kufotokozera Kwachidule:

Chiyero:≧99.0%

Miyezo Yabwino:Monga kufunikira

Chiphaso:COA, MOA, MSDS, etc.

Kuthekera:50Kgs pamwezi

Shelf Life:Zaka ziwiri

Ntchito:Inhibitor ya nonstructural protein 5A ndipo imagwiritsidwa ntchito pochiza matenda a chiwindi C

Ubwino wa Timu:Gulu lazogulitsa zogulitsa kunja ndi maphunziro aukadaulo kufakitale

Titumizireni imelo Tsitsani ngati PDF

Tsatanetsatane wa Zamalonda

FAQ

Zogulitsa Tags

Zogulitsadzina	Daclatasvir2HCl pa
Mawu ofanana ndi mawu	N,N'-[[1,1'-Biphenyl]-4,4′-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1) -methylethyl) -2-oxo-2,1-ethanediyl]]]biscarbamic asidi dimethyl ester hydrochloride;Mtengo wa BMS790052
CAS No.	1009119-65-6
Maonekedwe	ufa woyera mpaka wotumbululuka wachikasu
Molecular Formula	C₄₀H₅₀N₈O₆.2(HCl)
Kulemera kwa Maselo	811.81
Kugwiritsa ntchito	Gulu la Pharmaceutical cholinga cha Kafukufuku
Kulongedza	Monga mwa pempho lanu
Kusungirako	Sungani m'zotengera zolimba, zosagwira kuwala pamalo ozizira

Daclatasvir2HCl Cas:1009119-65-6
Zinthu	Standard	Zotsatira
Makhalidwe	ufa woyera mpaka wotumbululuka wachikasu	Pale-chikasu ufa
Zomwe zili m'madzi	≦1.0%	0.25%
Chiyero	≧99%	99.7%
Chidetso chimodzi	≦0.1%	0.06%
Zotsalira pakuyatsa	≦0.1%	Zimagwirizana
Mapeto	Imagwirizana ndi zomwe zili m'nyumba.

Zambiri Zamakampani

√ Kudziwa kwathunthu kwa Management layer mu otsatira fakitale ndi akatswiri aluso;
√ Quality nthawi zonse timaganizira kwambiri, Olimba QC dongosolo;
√ zaka 11 zokumana nazo zogulitsa kunja;
√ Independent R&D labu;
√ Misonkhano iwiri yosayinidwa yanthawi yayitali ya GMP;
√ Zida zolemera zamafakitale ambiri opanda pake pazosintha makonda;
√ Gulu logwira ntchito molimbika kwambiri lomwe lili ndi njira yosasinthika.
imgsaf